Revised SPC: RoActemra (tocilizumab) 162 mg Solution for Injection in Pre-Filled Pen

Tocilizumab is now licensed for active systemic juvenile idiopathic arthritis and juvenile idiopathic polyarthritis in patients 12 years of age and older. The entire SPC has been updated to incorporate prescribing information for this group of patients.


electronic Medicines compendium